Lingyan Xiao
Impact in
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- RNA modifications and cancer 4
-
- Ferroptosis and cancer prognosis 5
- Co-authors
- Xianglin Yuan (15 shared papers)Yongbiao Huang (12 shared papers)Zezhang Zhu (5 shared papers)Jun Qiao (5 shared papers)Bo Liu (10 shared papers)Zhen Liu (3 shared papers)Yishan Zheng (6 shared papers)Bangping Qian (4 shared papers)
- Journals
- Frontiers in Immunology (2 papers)Frontiers in Bioengineering and Biotechnology (2 papers)Cell Death and Disease (2 papers)Clinical Epigenetics (1 paper)PLoS ONE (1 paper)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Lingyan Xiao
33 papers receiving 210 citations
Peers
Comparison fields: 5 of 47
- Infectious Diseases 36
- Hepatology 11
- Cancer Research 20
- Neurology 16
- Pharmacology 9
Countries citing papers authored by Lingyan Xiao
This map shows the geographic impact of Lingyan Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingyan Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingyan Xiao more than expected).
Fields of papers citing papers by Lingyan Xiao
This network shows the impact of papers produced by Lingyan Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingyan Xiao. The network helps show where Lingyan Xiao may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingyan Xiao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 36 | |
| 2 | 2021 | 20 | |
| 3 | 2017 | 15 | |
| 4 | 2022 | 13 | |
| 5 | 2024 | 12 | |
| 6 | 2024 | 10 | |
| 7 | 2018 | 9 | |
| 8 | 2013 | 9 | |
| 9 | 2018 | 7 | |
| 10 | 2022 | 6 | |
| 11 | 2022 | 6 | |
| 12 | 2022 | 6 | |
| 13 | 2018 | 6 | |
| 14 | 2022 | 5 | |
| 15 | 2023 | 5 | |
| 16 | 2021 | 4 | |
| 17 | 2018 | 4 | |
| 18 | 2022 | 4 | |
| 19 | 2022 | 4 | |
| 20 | 2025 | 4 |
About Lingyan Xiao
Lingyan Xiao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Infectious Diseases and Surgery, having authored 34 papers that have together received 215 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (5 papers), Scoliosis diagnosis and treatment (4 papers), RNA modifications and cancer (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Immune cells in cancer (3 papers), Effects of Radiation Exposure (3 papers), COVID-19 Clinical Research Studies (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Infectious Diseases (36 citations), Hepatology (11 citations), Cancer Research (20 citations), Neurology (16 citations) and Pharmacology (9 citations). Lingyan Xiao has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Xianglin Yuan, Yongbiao Huang, Zezhang Zhu, Jun Qiao, Bo Liu, Zhen Liu, Yishan Zheng, Bangping Qian, Leilei Xu and Yong Qiu. Their work appears in journals such as Frontiers in Immunology, Frontiers in Bioengineering and Biotechnology, Cell Death and Disease, Clinical Epigenetics and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.